Showing results (2231-2240 of 2,376) with videos related to
Sort By:
Pageof 238
Current Developments in Nutrition|December 29, 2023
Fruit and Vegetable Intake of Females Before, During, and After Introduction of 3 Bundled Food System Interventions in Urban Vietnam and NigeriaGiulia Pastori, Inge D Brouwer, Meike Siemonsma, et al.Plos One|December 6, 2023
Involvement of an IgE/Mast cell/B cell amplification loop in abdominal aortic aneurysm progressionAlexia Loste, Marc Clément, Sandrine Delbosc, et al.Journal of Dentistry|November 19, 2021
Protein-based engineering of the initial acquired enamel pellicle in vivo: Proteomic evaluationTamara Teodoro Araújo, Thamyris Souza Carvalho, Aline Dionizio, et al.The Oncologist|June 6, 2018
CheckMate 141: 1-Year Update and Subgroup Analysis of Nivolumab as First-Line Therapy in Patients with Recurrent/Metastatic Head and Neck CancerMaura L Gillison, George Blumenschein, Jerome Fayette, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 2, 2023
Intravesical injections of botulinum neurotoxin A to treat overactive bladder and/or detrusor overactivity related to multiple sclerosis: 5-Year continuation rate and specific risk factors for discontinuation-A study from the neuro-urology committee of the French Association of UrologyStéphanie Delaval, Pierre-Luc Dequirez, Claire Hentzen, et al.Journal for Immunotherapy of Cancer|May 16, 2020
Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockadeRui Yang, Samah Elsaadi, Kristine Misund, et al.Journal of Dentistry|September 25, 2025
A new frontier in oral care with proteins and peptide infused in orally disintegrating film to prevent early dental erosion in vivoVinícius Taioqui Pelá, Gustavo Cassalate da Silva, Mariana Miranda de Brito, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2026
Pembrolizumab With or Without Lenvatinib as First-Line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Phase III LEAP-010 StudyLisa Licitra, Makoto Tahara, Kevin Harrington, et al.PNAS Nexus|December 11, 2023
A pan-SARS-CoV-2-specific soluble angiotensin-converting enzyme 2-albumin fusion engineered for enhanced plasma half-life and needle-free mucosal deliverySopisa Benjakul, Aina Karen Anthi, Anette Kolderup, et al.The Journal of Trauma and Acute Care Surgery|November 6, 2025
The use of ECMO in pediatric trauma resuscitation: A contemporary multicenter studyMary E Moya-Mendez, Victoria Donohue, Harold Leraas, et al.Pageof 238